« Back to Record
Van Laethem, J.-L., Geboes, K., Borbath, I., Macarulla Mercade, T., Lambert, A., Cassier, P. A., Prenen, H., Mitry, E., Blanc, J. F., Pilla, L., Feliu, J., Rodriguez Garrote, M., Pazo-Cid, R. A., Gallego, I., Smith, K. E., Nordbladh, K., Jimenez, D. G., Ellmark, P., Pico de Coaña, Y., Ambarkhane, S. V., Beatty, G. G., & O'Reilly, E. M. (2025). CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1. Cell Reports Medicine, 6(10), 102407. doi:10.1016/j.xcrm.2025.102407
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/402338



